间充质基质细胞通过细胞外囊泡线粒体转移在临床相关肺损伤模型中调节巨噬细胞
该研究探讨人间充质基质细胞(MSCs)对ARDS环境中巨噬细胞功能的旁分泌调节作用及细胞外囊泡(EV)介导的线粒体转移机制。方法采用人单核细胞来源巨噬细胞(MDMs)与MSCs非接触共培养(LPS或ARDS患者BALF刺激),以及小鼠肺泡巨噬细胞(AMs)经MSC来源EV预处理后过继转移至LPS损伤小鼠。结果显示MSCs抑制细胞因子产生、增加M2标志物表达并增强吞噬能力,这些效应部分由表达CD44的EV介导;抑制MDMs氧化磷酸化或使用罗丹明6G预处理MSCs产生功能失调线粒体均可消除上述效应。经MSC来源EV预处理的AMs过继转移可减轻LPS损伤小鼠的炎症和肺损伤。结论提示MSCs通过EV介导的线粒体转移促进抗炎高吞噬巨噬细胞表型,且该过程关键依赖于增强巨噬细胞氧化磷酸化。
要点
- 在ARDS环境下,MSCs可抑制LPS或ARDS BALF刺激的人MDMs细胞因子产生,并增加M2巨噬细胞标志物表达和吞噬能力。
- MSCs的这些调节效应部分由表达CD44的细胞外囊泡(EV)介导。
- 抑制MDMs氧化磷酸化或使用罗丹明6G预处理MSCs产生功能失调线粒体,均可消除MSCs对巨噬细胞的调节效应。
- 经MSC来源EV预处理的小鼠AMs过继转移至LPS损伤小鼠后可减轻炎症和肺损伤。
- MSC诱导的巨噬细胞表型改变关键依赖于增强巨噬细胞氧化磷酸化。
适用人群与场景
- 人单核细胞来源巨噬细胞(MDMs)在LPS或ARDS患者支气管肺泡灌洗液(BALF)刺激下与人间充质基质细胞(MSCs)非接触共培养。
- 小鼠肺泡巨噬细胞(AMs)在体外与或不与人间充质基质细胞来源的细胞外囊泡(EVs)共培养后,过继转移至LPS损伤小鼠。
研究设计与关键结果
- 研究类型:体外细胞实验与小鼠在体过继转移实验;样本量、中心数原文未报告。
- 人MDMs与MSCs非接触共培养(LPS或ARDS BALF刺激)时,MSCs抑制细胞因子产生、增加M2巨噬细胞标志物表达并增强吞噬能力。
- 上述效应部分由表达CD44的细胞外囊泡(EVs)介导。
- 经MSC来源EV预处理的小鼠AMs过继转移至LPS损伤小鼠,可减轻炎症和肺损伤。
- 抑制MDMs氧化磷酸化可阻止MSCs的调节效应。
- 使用罗丹明6G预处理MSCs产生功能失调线粒体,也可消除这些效应。
证据类型、等级与局限
- 证据类型:体外细胞实验与小鼠在体实验(非临床研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论提示,在ARDS环境中MSCs通过EV介导的线粒体转移促进抗炎且高吞噬能力的巨噬细胞表型,该效应关键依赖于增强巨噬细胞氧化磷酸化。
- 经MSC来源EV预处理的小鼠AMs过继转移可减轻LPS损伤小鼠的肺损伤,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Acute respiratory distress syndrome (ARDS) remains a major cause of respiratory failure in critically ill patients. Mesenchymal stromal cells (MSCs) are a promising candidate for a cell-based therapy. However, the mechanisms of MSCs' effects in ARDS are not well understood. In this study, we focused on the paracrine effect of MSCs on macrophage polarization and the role of extracellular vesicle (EV)-mediated mitochondrial transfer.
OBJECTIVES: To determine the effects of human MSCs on macrophage function in the ARDS environment and to elucidate the mechanisms of these effects.
METHODS: Human monocyte-derived macrophages (MDMs) were studied in noncontact coculture with human MSCs when stimulated with LPS or bronchoalveolar lavage fluid (BALF) from patients with ARDS. Murine alveolar macrophages (AMs) were cultured ex vivo with/without human MSC-derived EVs before adoptive transfer to LPS-injured mice.
MEASUREMENTS AND MAIN RESULTS: MSCs suppressed cytokine production, increased M2 macrophage marker expression, and augmented phagocytic capacity of human MDMs stimulated with LPS or ARDS BALF. These effects were partially mediated by CD44-expressing EVs. Adoptive transfer of AMs pretreated with MSC-derived EVs reduced inflammation and lung injury in LPS-injured mice. Inhibition of oxidative phosphorylation in MDMs prevented the modulatory effects of MSCs. Generating dysfunctional mitochondria in MSCs using rhodamine 6G pretreatment also abrogated these effects.
CONCLUSIONS: In the ARDS environment, MSCs promote an antiinflammatory and highly phagocytic macrophage phenotype through EV-mediated mitochondrial transfer. MSC-induced changes in macrophage phenotype critically depend on enhancement of macrophage oxidative phosphorylation. AMs treated with MSC-derived EVs ameliorate lung injury in vivo.
参考来源
- Morrison TJ, Jackson MV, Cunningham EK, et al. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. Am J Respir Crit Care Med. 2017. PMID: 28598224. doi:10.1164/rccm.201701-0170OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。